SCHEMBL9204491

SCHEMBL9204491

CC(C)(C)C(=O)Sc1ccc(-c2nc3n(c2-c2ccncc2)CCC3)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.50
CSNK1D P48730 5/20 0.41
CSNK1E P49674 5/20 0.41
TGFBR1 P36897 5/20 0.41
TGFBR2 P37173 2/20 0.40
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MAPK14 Q16539 5/20 0.35
MAPK13 O15264 4/20 0.35
MAPK12 P53778 4/20 0.35
MAPK11 Q15759 4/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GCGR P47871 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9198368 0.88 PDE10A (0.53) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL9701093 0.85 PDE10A (0.50) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL7377438 0.82 PDE10A (0.43) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL7352490 0.82 PDE10A (0.60) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL7377231 0.82 PDE10A (0.60) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL9699916 0.80 PDE10A (0.47) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL9698897 0.79 PDE10A (0.48) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL7376921 0.79 PDE10A (0.54) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL9700092 0.78 PDE10A (0.56) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2
SCHEMBL7378897 0.78 PDE10A (0.48) PDE10ACSNK1DCSNK1ETGFBR1TGFBR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0306300-B1 Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors SMITHKLINE BEECHAM CORP (US) 1995-05-03 EP claimed
US-5002941-A Antiarthritic agents, arachidonic acid metabolism SMITHKLINE BEECHAM CORPORATION (US) 1991-03-26 US claimed
WO-1990003789-A1 PYRROLO[1,2-a]IMIDAZOLE AND IMIDAZO[1,2-a]PYRIDINE DERIVATIVES AND THEIR USE AS 5-LYPOXYGENASE PATHWAY INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1990-04-19 WO claimed
EP-0364204-A1 Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1990-04-18 EP claimed
EP-0306300-A2 Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1989-03-08 EP claimed
EP-0306300-B1 Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors SMITHKLINE BEECHAM CORP (US) 1995-05-03 EP disclosed
US-5145858-A Antiinflammatory SMITHKLINE BEECHAM CORP. (US) 1992-09-08 US disclosed
WO-1990003789-A1 PYRROLO[1,2-a]IMIDAZOLE AND IMIDAZO[1,2-a]PYRIDINE DERIVATIVES AND THEIR USE AS 5-LYPOXYGENASE PATHWAY INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1990-04-19 WO disclosed
EP-0364204-A1 Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1990-04-18 EP disclosed
EP-0306300-A2 Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1989-03-08 EP disclosed